312 related articles for article (PubMed ID: 15759207)
1. Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.
Gillams A; Cassoni A; Conway G; Lees W
Abdom Imaging; 2005; 30(4):435-41. PubMed ID: 15759207
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases.
Berber E; Flesher N; Siperstein AE
World J Surg; 2002 Aug; 26(8):985-90. PubMed ID: 12016479
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation of colorectal liver metastases.
Gillams AR; Lees WR
Abdom Imaging; 2005; 30(4):419-26. PubMed ID: 15759208
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation of neuroendocrine liver metastases.
Elvin A; Skogseid B; Hellman P
Abdom Imaging; 2005; 30(4):427-34. PubMed ID: 15791486
[No Abstract] [Full Text] [Related]
6. Radiofrequency ablation for the treatment of liver tumors in the caudate lobe.
Seror O; Haddar D; N'Kontchou G; Ajavon Y; Trinchet JC; Beaugrand M; Sellier N
J Vasc Interv Radiol; 2005 Jul; 16(7):981-90. PubMed ID: 16002506
[TBL] [Abstract][Full Text] [Related]
7. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].
Fendrich V; Habbe N; Celik I; Langer P; Zielke A; Bartsch DK; Rothmund M
Dtsch Med Wochenschr; 2007 Feb; 132(5):195-200. PubMed ID: 17252361
[TBL] [Abstract][Full Text] [Related]
8. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases.
Gillams AR; Lees WR
J Vasc Interv Radiol; 2008 May; 19(5):712-7. PubMed ID: 18440460
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors.
Jensen EH; Kvols L; McLoughlin JM; Lewis JM; Alvarado MD; Yeatman T; Malafa M; Shibata D
Ann Surg Oncol; 2007 Feb; 14(2):780-5. PubMed ID: 17146740
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation of liver metastases from breast cancer: results in 14 patients.
Gunabushanam G; Sharma S; Thulkar S; Srivastava DN; Rath GK; Julka PK; Bhatnagar S
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):67-72. PubMed ID: 17296706
[TBL] [Abstract][Full Text] [Related]
11. [Radiofrequency ablation of colorectal liver metastases].
Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
[TBL] [Abstract][Full Text] [Related]
12. Serotonin release during percutaneous radiofrequency ablation in a patient with symptomatic liver metastases of a neuroendocrine tumor.
Wettstein M; Vogt C; Cohnen M; Brill N; Kurz AK; Mödder U; Häussinger D
Hepatogastroenterology; 2004; 51(57):830-2. PubMed ID: 15143927
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery in patients with advanced-stage carcinoid tumors.
Gulec SA; Mountcastle TS; Frey D; Cundiff JD; Mathews E; Anthony L; O'Leary JP; Boudreaux JP
Am Surg; 2002 Aug; 68(8):667-71; discussion 671-2. PubMed ID: 12206599
[TBL] [Abstract][Full Text] [Related]
14. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
15. [Radiofrequency ablation of colorectal liver metastases].
Frich L; Brabrand K; Aaløkken TM; Edwin B; Gladhaug IP
Tidsskr Nor Laegeforen; 2008 Jan; 128(1):57-60. PubMed ID: 18183060
[TBL] [Abstract][Full Text] [Related]
16. The role of radiofrequency ablation in the treatment of primary and metastatic tumours of the liver: initial lessons learned.
Choy PY; Koea J; McCall J; Holden A; Osbourne M
N Z Med J; 2002 Aug; 115(1159):U128. PubMed ID: 12362172
[TBL] [Abstract][Full Text] [Related]
17. Complications from radiofrequency ablation of liver metastases.
Zagoria RJ; Chen MY; Shen P; Levine EA
Am Surg; 2002 Feb; 68(2):204-9. PubMed ID: 11845810
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation for the management of liver tumors.
Bachar GN; Greif F; Mor E; Tur-Kaspa R; Belenky A
Isr Med Assoc J; 2003 Jul; 5(7):496-500. PubMed ID: 12901246
[TBL] [Abstract][Full Text] [Related]
19. Clinical short-term results of radiofrequency ablation in patients with liver metastases from colorectal cancer.
Basdanis G; Michalopoulos A; Papadopoulos V; Tzeveleki I; Efthimiadis Ch; Kosmidis Ch; Mekras D; Harlaftis N
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s187-9. PubMed ID: 15655617
[TBL] [Abstract][Full Text] [Related]
20. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients.
Lorentzen T; Skjoldbye BO; Nolsoe CP
Ultraschall Med; 2011 Oct; 32(5):492-6. PubMed ID: 21259183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
